Literature DB >> 16828305

Neuroblastoma as an experimental model for neuronal differentiation and hypoxia-induced tumor cell dedifferentiation.

Anders Edsjö1, Linda Holmquist, Sven Påhlman.   

Abstract

Neuroblastoma is a childhood tumor derived from precursor or immature cells of the sympathetic nervous system. Neuroblastomas show a tremendous clinical heterogeneity, encompassing truly benign as well as extremely aggressive forms. In vivo as well as in vitro data have shown that the degree of sympathetic neuronal tumor cell differentiation influences patient outcome. Unraveling mechanisms governing neuroblastoma cell differentiation is therefore a central issue in the neuroblastoma research field. In this communication, we discuss some of the in vitro models frequently used to study human neuroblastoma cell differentiation. We also review recent data demonstrating that oxygen shortage, hypoxia, shifts neuroblastoma cells toward an immature, stem cell-like phenotype and discuss the potential clinical impact of hypoxia on neuroblastoma behavior.

Entities:  

Mesh:

Year:  2006        PMID: 16828305     DOI: 10.1016/j.semcancer.2006.04.005

Source DB:  PubMed          Journal:  Semin Cancer Biol        ISSN: 1044-579X            Impact factor:   15.707


  38 in total

1.  Proteolytic control of neurite outgrowth inhibitor NOGO-A by the cAMP/PKA pathway.

Authors:  Maria Sepe; Luca Lignitto; Monia Porpora; Rossella Delle Donne; Laura Rinaldi; Giuseppe Belgianni; Gianna Colucci; Ornella Cuomo; Davide Viggiano; Antonella Scorziello; Corrado Garbi; Lucio Annunziato; Antonio Feliciello
Journal:  Proc Natl Acad Sci U S A       Date:  2014-10-20       Impact factor: 11.205

2.  Neoglucosylated collagen matrices drive neuronal cells to differentiate.

Authors:  Laura Russo; Antonella Sgambato; Marzia Lecchi; Valentina Pastori; Mario Raspanti; Antonino Natalello; Silvia M Doglia; Francesco Nicotra; Laura Cipolla
Journal:  ACS Chem Neurosci       Date:  2014-03-19       Impact factor: 4.418

3.  Sub-micromolar concentrations of retinoic acid induce morphological and functional neuronal phenotypes in SK-N-SH neuroblastoma cells.

Authors:  Emily Harasym; Nicole McAndrew; George Gomez
Journal:  In Vitro Cell Dev Biol Anim       Date:  2017-08-24       Impact factor: 2.416

4.  Type III TGF-β receptor promotes FGF2-mediated neuronal differentiation in neuroblastoma.

Authors:  Erik H Knelson; Angela L Gaviglio; Alok K Tewari; Michael B Armstrong; Karthikeyan Mythreye; Gerard C Blobe
Journal:  J Clin Invest       Date:  2013-11       Impact factor: 14.808

5.  Neuroblastoma phox2b variants stimulate proliferation and dedifferentiation of immature sympathetic neurons.

Authors:  Tobias Reiff; Konstantina Tsarovina; Afsaneh Majdazari; Mirko Schmidt; Isabel del Pino; Hermann Rohrer
Journal:  J Neurosci       Date:  2010-01-20       Impact factor: 6.167

6.  MYCN-regulated microRNAs repress estrogen receptor-alpha (ESR1) expression and neuronal differentiation in human neuroblastoma.

Authors:  Jakob Lovén; Nikolay Zinin; Therese Wahlström; Inga Müller; Petter Brodin; Erik Fredlund; Ulf Ribacke; Andor Pivarcsi; Sven Påhlman; Marie Henriksson
Journal:  Proc Natl Acad Sci U S A       Date:  2010-01-04       Impact factor: 11.205

7.  Stromal heparan sulfate differentiates neuroblasts to suppress neuroblastoma growth.

Authors:  Erik H Knelson; Angela L Gaviglio; Jasmine C Nee; Mark D Starr; Andrew B Nixon; Stephen G Marcus; Gerard C Blobe
Journal:  J Clin Invest       Date:  2014-06-17       Impact factor: 14.808

8.  Differentiation in neuroblastoma: diffusion-limited hypoxia induces neuro-endocrine secretory protein 55 and other markers of a chromaffin phenotype.

Authors:  Fredrik Hedborg; Reiner Fischer-Colbrie; Nurtena Ostlin; Bengt Sandstedt; Maxine G B Tran; Patrick H Maxwell
Journal:  PLoS One       Date:  2010-09-17       Impact factor: 3.240

9.  High Myc pathway activity and low stage of neuronal differentiation associate with poor outcome in neuroblastoma.

Authors:  Erik Fredlund; Markus Ringnér; John M Maris; Sven Påhlman
Journal:  Proc Natl Acad Sci U S A       Date:  2008-09-09       Impact factor: 11.205

10.  LMNA knock-down affects differentiation and progression of human neuroblastoma cells.

Authors:  Giovanna Maresca; Manuela Natoli; Marta Nardella; Ivan Arisi; Daniela Trisciuoglio; Marianna Desideri; Rossella Brandi; Simona D'Aguanno; Maria Rita Nicotra; Mara D'Onofrio; Andrea Urbani; Pier Giorgio Natali; Donatella Del Bufalo; Armando Felsani; Igea D'Agnano
Journal:  PLoS One       Date:  2012-09-26       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.